Form 4 for UNCY Unicycive Therapeutics, Inc.
Accepted 2022-08-30 00:00:00 ET · period of report 2022-07-15 · accession 0001213900-22-052329 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-30 | 2022-07-15 | UNCY | Schiller Brigitte | Dir | M - OptEx | $0.00 | +26.7K | 26.7K | New | $0 |
| D | 2022-08-30 | 2022-07-15 | UNCY | Schiller Brigitte | Dir | M - OptEx | $0.00 | -26.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-15 | M | A | 26,738 | $0.00 | 26,738 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2022-07-15 | M | D | 26,738 | $0.00 | 0 | D | — · — to — | 26,738 Common Stock | (F2) Each restricted stock unit is the economic equivalent of one share of Unicycive Therapeutics common stock. (F3) On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022. The common stock into which such vested restricted stock units converted on July 15, 2022 is reported in Table I on this Form 4. |